Precision Cancer Medicine & Oncology

Precision medicine is the tailoring of medical treatment to the individual characteristics of each patient and his or her disease. Moreover, through the precision medicine approach, the treatment of each patient can be focused on drugs most likely to benefit him or her, sparing the patient the cost and potential harmful side effects from drugs that are unlikely to be beneficial. Oncology has been leading precision medicine efforts largely because of our immense knowledge of the role of genetic mutations in the development and progression of cancer. Precision medicine enables to approach detection, diagnosis and treatment in an in-depth way to determine how a cancer develops, grows and spreads.

 Cancer Epidemiology

Cancer Epidemiology includes the study of the factors affecting cancer, to infer possible trends and causes. The study of cancer epidemiology uses epidemiological methods to find the cause of cancer and to identify and develop improved treatments. It can be used to identify events that increase or decrease cancer incidence in specific populations. The studies related to population-based research on cancer etiology, prevention, surveillance and survivorship, analytical, and molecular epidemiology, survivorship studies, risk factors, as well as the role of behavioural factors in cancer etiology and prevention are also included.

 Cancer Therapy & Treatments

Cancer can be treated by different processes. The choice of therapy depends upon the location and grade of the tumour and the stage of the disease, as well as the general state of the patient). Many experimental cancer treatments are also under development. Some people with cancer will have only one treatment. But most people have a combination of treatments, such as surgery with chemotherapy and/or radiation therapy. You may also have immunotherapy, targeted therapy, or hormone therapy.

Cancer Immunology & Immunotherapy

Cancer immunology is a branch of immunology that studies interactions between the immune system and cancer cells (also called tumours or malignancies). It is a field of research that aims to discover cancer immunotherapies to treat and retard progression of the disease. Cancer immunotherapy also known as Immuno-oncology is the use of the immune system to treat cancer. Immunotherapies can be categorized as active, passive or hybrid (active and passive). The immune response, including the recognition of cancer-specific antigens, forms the basis of targeted therapy (such as vaccines and antibody therapies) and tumour marker-based diagnostic tests.

Oncology Nursing and Care

Oncology Nursing is a field involving practice encompasses the roles of direct caregiver, educator, consultant, administrator, and researcher. Oncology and cancer nursing extends to all care delivery settings where clients experiencing or at risk for developing cancer receive health care, education, and counselling for cancer prevention, screening and detection. It also involves appropriate screenings and other preventative practices, symptom management, care to retain as much normal functioning as possible, and supportive measures upon end of life.

 Complementary & Alternative Methods and Cancer

Alternative cancer treatments may not play a direct role in curing your cancer, but they may help you cope with signs and symptoms caused by cancer and cancer treatments. CAM is the term for medical products and practices that are not part of standard care. Integrating the best of evidence-based complementary and alternative cancer treatments with the treatments you receive from your doctor may help relieve many of the symptoms associated with cancer and its treatment.

 Cancer Prevention & Research

Cancer prevention is defined as active measures to decrease the risk of cancer. Most of cancer cases are due to environmental risk factors, and many, but not all, of these environmental factors are controllable lifestyle choices. An individual's risk of developing cancer can be substantially reduced by healthy behaviour. Cancer Prevention Research comprises preclinical, clinical and translational research, with special attention given to molecular discoveries and an emphasis on building a translational bridge between the basic and clinical sciences.

 Cancer: Lifestyle Connection and Nutrition

Many factors influence the development of cancer. Over the last 25 years, science has shown that diet, physical activity, and body weight—especially being overweight or obese—are major risk factors for developing certain types of cancer. Around a third of the most common cancers could be prevented through lifestyle changes. The main behavioural and environmental risk factors for cancer mortality in the world are related to diet and physical inactivity, use of addictive substances, sexual and reproductive health and exposure to air pollution and use of contaminated needles. The body’s ability to resist cancer may be helped by following a healthy diet, staying physically active, and avoiding excess body fat.  Cancer and cancer treatments can also affect your body's ability to tolerate certain foods and use nutrients.

 Tumour Virology, Immunology & Cellular Pathology

Tumour virology deals with the specific virus infections and cancer, oncogenes, tumour suppressors, oncogenic cofactors, disruption of innate/ adaptive immune responses, latency, and viral mimicry/piracy of cellular regulatory genes, genomic instability and role of non-coding RNAs in viral pathogenesis. The purpose of this study is to develop viral vectors for human cancer gene therapy and to progress vaccine strategies for treatment of viral-associated cancers. Several methods are being trailed including genetic immunization with recombinant viral vectors based on Semliki Forest virus, immune checkpoint inhibitors and strategies to re-modulate the immunosuppressive tumor environment.

 Cancer Metabolomics

Cancer genomics deals with the characterization difference between the cancer cells and normal cells based on gene expression and sequence of the DNA. The purpose of this study is to understand the basic genetics of tumor progression, development of genome of cancer by mutation and the action of drug in the cancer micro environment.  Metabolomics is the study of the chemical fingerprints left by a metabolite during metabolism. In case of cancer cells, it will be very useful to study the metabolite profile for drug development. Many discoveries are being made in cancer metabolomics, one of them is the noninvasive validation of metabolic biomarkers from the body fluid of cancer patients. Cancer Cell Biology makes the better understanding of the chemical changes happening inside cancer cells. Cancer Science Conferences provides a multidisciplinary knowledge to cancer researchers.

 Neonatal & Paediatric Oncology

Neonatal & Pediatric Oncology is the term used to comprise all malignant conditions among neonates & children with cancer. The most common childhood cancers are leukaemia (begins in blood-forming tissue such as bone marrow), lymphoma (cancer in the cells of immune system), neuroblastoma (nerve cells), retinoblastoma (occurs in the tissues of the retina), Wilms tumour (kidney cancer), and brain tumors, such as gliomas. Childhood cancers are very rare and may differ from adult cancers in the way they grow, spread, treated, and respond to treatment.

 Cancer Awareness and Survival

Increased cancer awareness improves survival. Social and Economic Impact also harm the quality of cancer care. People who are not financially not strong do not receive good treatment. Cancer symptom awareness and cancer survival are associated. Cancer Awareness Program is conducted by government and many organizations to bring the awareness in the people to decrease the cancer levels & towards all oncology programs. Campaigns should focus on improving awareness about cancer symptoms, especially in socioeconomically deprived areas.

 Cancer Metastasis

The spread of cancer from one part of the body to another part or to lymph nodes, which are not directly connected to each other, is called cancer metastasis. Cancer is considered as a deadly disease mainly because of its ability to spread in the body. This metastasis takes place through the blood stream or the lymph system. The most common metastasis parts of the body are the lungs, bones, liver and brain. The metastatic cancer cells does not resemble the feature of the cells where it was found but it resembles the primary cancer cells i.e. it was considered as a next stage of the primary cancer cells. All metastatic cancers are considered as advanced cancers. The cancer survival and treatment is influenced by whether the cancer cells are localized or spreads to other parts. When the cancer starts to spread it is very difficult to control. Even if the treatment is continued, it will be only palliative care. The pain killing will be mostly by Anti-cancer drugs i.e. chemotherapy. Cancer Management is a multidisciplinary approach that deals with the various type of cancer complications and its preventive measures. Cancer Conferences is an important key for both educational and clinical guidance for managing cancer patients.

The journal invites different types of articles including original research article, review articles, short note communications, case reports, Editorials, letters to the Editors and expert opinions & commentaries from different regions for publication.

 The Journals includes around 150Abstracts and 100 Keynote speakers have given their valuable words. The meet has provided a great scope for interaction of professionals including in addition to clinical experts and top-level pathologists and scientists from around the globe, on a single platform.

Media Contact:
ALPINE
Managing Editor
Journal of Molecular Oncology Research
Email: oncology@openaccessjournal.org
Watsapp:+ +44-1470-490003